# Sana Biotechnology, Inc. > Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero. ## Record | Field | Value | | --- | --- | | Representation | alpha-profile-markdown-v4 | | Protocol | Alpha Governance Facts Protocol 0.1 | | Schema | alpha.governance.entity.public.v1 | | Record version | public-1 | | Governance record representation | alpha-governance-record-v2 | | Canonical entity | alpha:company:efda9614-03aa-400b-958e-bfae693103b2 | | Entity type | Company | | Canonical URL | https://registry.alpha.ac/companies/sana-biotechnology-inc | | Publication | PUBLISHED | | Verification | source_reported | | Verification schema | alpha-verification-states-v1 | | Ownership | unclaimed | | Published claims | 19 | | Claims under review | 1 | | Evidence records | 4 | | Conflicts | 0 | | Conflicts in internal review | 0 | | Observed | 2026-09-28T04:46:20.979603+00:00 | | Last reviewed | 2026-09-28T04:46:20.979603+00:00 | ## Identity - Legal name: Sana Biotechnology, Inc. - Display name: Sana Biotechnology, Inc. ## Role modules - NOT_ASSERTED ## Attention - NO_RECORDS_FOUND ## Committee data - NO_RECORDS_FOUND ## Leadership - Hans E. Bishop: Chairman of the Board. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:5. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:2. - Alise S. Reicin: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:6. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:3. - Alise S. Reicin, M.D.: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:7. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:2. - Joshua H. Bilenker: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:8. Valid from: 2020-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:3. - Joshua H. Bilenker, M.D.: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:9. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:2. - Mary Agnes Wilderotterº: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:10. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:3. - Michelle Seitz, CFA: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:11. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:2. - Patrick Y. Yang: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:12. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:3. - Patrick Y. Yang, Ph.D.: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:13. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:2. - Richard Mulligan: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:14. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:3. - Richard Mulligan, Ph.D.: Vice-Chairman of the Board. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:15. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:2. - Robert L. Rosiello: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:16. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:2. - Robert Nelsen: Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:17. Valid from: 2018-01-01. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:3. - Steven D. Harr, M.D.: President, Chief Executive Officer and Director. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:18. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:2. - Bernard J. Cassidy: Chief Financial Officer. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:19. Valid from: 2026-04-24. Valid to: NOT_ASSERTED. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:4. - Steven D. Harr, M.D.: President and Chief Executive Officer. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:leadership_role:20. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:2. ## Roles - PUBLISHED ## Governance - NOT_ASSERTED ## Board committees - PUBLISHED ## Financials - NOT_ASSERTED ## Workforce - NOT_ASSERTED ## Market and index context - PUBLISHED ## Legal Name - Sana Biotechnology, Inc.. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:legal_name:1. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:1. ## Entity Status - Public listing published. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:entity_status:3. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:1. ## Published Fact - US. Claim: alpha:claim:company:efda9614-03aa-400b-958e-bfae693103b2:published_fact:4. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:1. ## Coverage states | Field | Value | | --- | --- | | Identity | PUBLISHED | | Business | PUBLISHED | | Leadership | PUBLISHED | | Board and committees | PUBLISHED | | Governance | NOT_ASSERTED | | Financials | NOT_ASSERTED | | Workforce | NOT_ASSERTED | | Ownership | NOT_ASSERTED | | Ratings | NOT_PUBLISHED | | Market and index context | PUBLISHED | ## Public sources - alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:1: [Alpha canonical company public projection](https://www.alpha.ac/api/public/companies/sana-biotechnology-inc). - alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:2: [SEC DEF 14A 0001193125-26-174883](https://www.sec.gov/Archives/edgar/data/1770121/000119312526174883/d42230ddef14a.htm). - alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:3: [DEF 14A d42230ddef14a.htm](https://www.sec.gov/Archives/edgar/data/1770121/000119312526174883/d42230ddef14a.htm). - alpha:evidence:company:efda9614-03aa-400b-958e-bfae693103b2:4: [SANA DEF 14A executive officers](https://www.sec.gov/Archives/edgar/data/1770121/000119312526174883/d42230ddef14a.htm). ## Rights | Field | Value | | --- | --- | | public_retrieval | allowed | | agent_retrieval | allowed | | redistribution | not_granted | | model_training | not_granted | | commercial_use | not_specified | | relationship_pathfinding | not_granted | | direct_contact | not_granted | ## Limitations - Absence of a leadership role, committee, or disclosure is not evidence that it does not exist. - Only explicitly published canonical company identity and current confirmed public roles are included. - Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist. - Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights. - This Company Profile is an identity and evidence record, not an Alpha rating. ## Alternate representations - [Canonical profile](https://registry.alpha.ac/companies/sana-biotechnology-inc) - [Public Markdown](https://registry.alpha.ac/companies/sana-biotechnology-inc.md) - [Public JSON](https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=record) - [JSON-LD](https://registry.alpha.ac/api/public/companies/sana-biotechnology-inc?format=jsonld) - MCP resource: `alpha://companies/sana-biotechnology-inc` at https://mcp.alpha.ac/mcp ## Connected governance records Structured intelligence is not currently available. Existing published profile evidence remains accessible.